McGuff Outsourcing Solutions (MOS) operates within a commercial pharmaceutical manufacturer with FDA-approved drug experience, bringing manufacturing-grade systems, oversight, and discipline to compounded sterile medications.
If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.
McGuff Outsourcing Solutions (MOS) operates within a commercial pharmaceutical manufacturer with FDA-approved drug experience, bringing manufacturing-grade systems, oversight, and discipline to compounded sterile medications.
Since the enactment of the Drug Quality and Security Act (DQSA) in 2013, McGuff has remained actively engaged in supporting science-based regulatory decision-making related to compounded sterile drug products, with a consistent focus on patient safety, product quality, and regulatory transparency.
Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.
In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.
Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.
As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.